EUVIMEDEUVIMED entdecken
Crossref

The Small Molecule Inhibitor of the Wnt–β‐Catenin Pathway, CWP232291 , Inhibits Tumor Growth in Preclinical Models of Salivary Gland Adenoid Cystic Carcinoma

Joseph O Humtsoe iD, Bhumsuk Keam iD, Hyun-Su Kim, Leilani Jones iD, Brandon Leonard, Anita Pothukuchi, Sarah Honjo, Annemieke van Zante, Susan Lee iD, Patrick K Ha iD

Head & Neck · 2025-12 · 47 (12) · 3321-3330

DOI: 10.1002/hed.28249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, online erschienen am 17.07.2025. Verfasst von Joseph O Humtsoe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Fran…. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms, Wnt Signaling Pathway. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: NIDCR NIH HHS, National Institute of Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Salivary gland adenoid cystic carcinoma (ACC) is a rare and challenging form of head and neck cancer, particularly difficult to treat once it progresses to recurrent or metastatic disease. In this study, we evaluate the cytotoxicity and anti‐tumorigenic effects of CWP232291, a first‐in‐class small molecule inhibitor targeting the Wnt–β‐catenin signaling pathway.

Methods

Tumor microarrays of ACC patients and patient‐derived xenografts (PDX) were evaluated by immunohistochemistry, RNA‐seq, and qRT‐PCR analysis for β‐catenin. The effects of CWP232291 were determined by cytotoxic, qRT‐PCR, and immunoblotting analysis. In vivo anti‐tumorigenic effects of CWP232291 were evaluated using cell line xenograft and PDX models.

Results

Immunohistochemistry analysis revealed that high β‐catenin expression correlated with reduced overall survival in ACC patients. Expression of genes involved in the Wnt–β‐catenin pathway was enriched in PDX samples. In vitro cytotoxicity and biochemical assays using MDA‐ACC‐01 and UM‐HACC‐2A cell lines revealed that ACC cells were susceptible to CWP232291. Furthermore, CWP232291 treatment attenuated in vivo tumor growth in both cell line xenograft and PDX models.

Conclusions

Abnormal Wnt–β‐catenin signaling may play an active role in ACC pathogenesis, and its inhibition by CWP232291 may offer therapeutic potential, representing a promising avenue for further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Adenoid CysticSalivary Gland NeoplasmsWnt Signaling PathwayHumansAnimalsMiceXenograft Model Antitumor AssaysCell Line, Tumorbeta CateninFemaleMaleCell Proliferation

Stichwörter der Autor:innen

CWP232291Wnt/β‐catenin signalingadenoid cystic carcinomapatient‐derived xenograft

Substanzen

beta Catenin

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Department of Pathology, University of California San Francisco, San Francisco, California, USA.
  • Department of Oral and Maxillofacial Surgery, University of California San Francisco, San Francisco, California, USA.

ORCID-Profile: Joseph O Humtsoe, Bhumsuk Keam, Leilani Jones, Susan Lee, Patrick K Ha

Förderung

  • NIDCR NIH HHS
  • National Institute of Dental and Craniofacial Research

Zitieren

APA

Humtsoe, J. O., Keam, B., Kim, H. S., Jones, L., Leonard, B., Pothukuchi, A., Honjo, S., van Zante, A., Lee, S., & Ha, P. K. (2025). The Small Molecule Inhibitor of the Wnt–β‐Catenin Pathway, CWP232291 , Inhibits Tumor Growth in Preclinical Models of Salivary Gland Adenoid Cystic Carcinoma. Head & Neck, 47(12), 3321-3330. https://doi.org/10.1002/hed.28249

Vancouver

Humtsoe JO, Keam B, Kim HS, Jones L, Leonard B, Pothukuchi A, et al. The Small Molecule Inhibitor of the Wnt–β‐Catenin Pathway, CWP232291 , Inhibits Tumor Growth in Preclinical Models of Salivary Gland Adenoid Cystic Carcinoma. Head & Neck. 2025;47(12):3321-3330. doi:10.1002/hed.28249

BibTeX
@article{Humtsoe2025,
  author = {Humtsoe, Joseph O and Keam, Bhumsuk and Kim, Hyun-Su and Jones, Leilani and Leonard, Brandon and Pothukuchi, Anita and Honjo, Sarah and van Zante, Annemieke and Lee, Susan and Ha, Patrick K},
  title = {The Small Molecule Inhibitor of the Wnt–β‐Catenin Pathway, CWP232291 , Inhibits Tumor Growth in Preclinical Models of Salivary Gland Adenoid Cystic Carcinoma},
  journal = {Head & Neck},
  year = {2025},
  volume = {47},
  number = {12},
  pages = {3321--3330},
  doi = {10.1002/hed.28249}
}
Kostenlos starten →